Pyxis Oncology

Pyxis Oncology is a company listed under the stock ticker PYXS (US).

Acquisition, funding and merger involving Pyxis Oncology.

• Pyxis Oncology has announced the acquisition of Apexigen  (posted on May 26 2023).

View the org chart displaying its 14 main executives

Most searched biographies at Pyxis Oncology

• Lara Sullivan, Chief Executive Officer and Director
• Rachel Humphrey, Director
• Darren Cline, Director

Popular executive movements at Pyxis Oncology

• Santhosh Palani has joined the company as Director  (posted on March 14 2024).
• Ken Kobayashi has joined the company as Chief Medical Officer  (posted on November 28 2023).
• Jakob Dupont has joined the company as Director  (posted on August 24 2023).

Create your alert
to follow the executive moves at Pyxis Oncology.

Pyxis Oncology has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Pyxis Oncology

• Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Pyxis Oncology
• Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights | Pyxis Oncology
• Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 | Pyxis Oncology
• Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA | Pyxis Oncology
• Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 | Pyxis Oncology
• Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting | Pyxis Oncology
• Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Pyxis Oncology
• Pyxis Oncology Announces $50 Million Private Placement | Pyxis Oncology
• Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update | Pyxis Oncology
• Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 | Pyxis Oncology
• View more press releases Close

Social media about Pyxis Oncology

• Pyxis Oncology on Wikipedia, Google News & Yahoo Finance
• Pyxis Oncology on LinkedIn, Twitter & YouTube

Contact by email its executives including Lara Sullivan

Call Pyxis Oncology at +1 1 ...

View the org chart

Register to receive your alert

Report an error